| Literature DB >> 23378430 |
Lei Jin1, Andrew Getahun, Heather M Knowles, Jennifer Mogan, Linda J Akerlund, Thomas A Packard, Anne-Laure Perraud, John C Cambier.
Abstract
MPYS (also known as STING, MITA, and TMEM173) is a type I IFN stimulator that is essential for host defense against DNA virus infection and appears important in defense against certain bacteria. The in vivo significance and mechanisms by which MPYS mediates host defense against nonviral pathogens are unknown. Using an MPYS-deficient mouse (Tmem173(<tm1Camb>)), we determined that, distinct from the IFNAR(-/-) mice, MPYS deficiency leads to increased bacterial burden in the liver upon Listeria monocytogenes infection. The increase was correlated with the diminished MCP-1 and MCP-3 chemokine production and decreased blood and liver Ly6C(hi) monocyte frequency. We further demonstrate that MPYS-deficient Ly6C(hi) monocytes are intrinsically defective in migration to the liver. Lastly, adoptive transfer of wild-type Ly6C(hi) monocyte into MPYS-deficient mice decreases their liver bacterial burden. Our findings reveal a novel in vivo function of MPYS that is distinct from its role in activating type I IFN production.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23378430 PMCID: PMC3593745 DOI: 10.4049/jimmunol.1201788
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422